USP39 and melanoma: found that USP39 activates the MAPK signaling pathway by inhibiting the phosphorylation modification of ERK1/2, which promotes tumor progression (51), suggesting that the regulation of cellular function by USP39 in melanoma may function by affecting key molecules of the signaling pathway.